{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T18:41:24Z","timestamp":1792521684726,"version":"4.5.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"vor","delay-in-days":730,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["UL1TR002378"],"award-info":[{"award-number":["UL1TR002378"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["5T32HL116271"],"award-info":[{"award-number":["5T32HL116271"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["CFF 00812F221"],"award-info":[{"award-number":["CFF 00812F221"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["KAVAL20QI0"],"award-info":[{"award-number":["KAVAL20QI0"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","cysticfibrosisjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cystic Fibrosis"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.jcf.2024.03.005","type":"journal-article","created":{"date-parts":[[2024,3,10]],"date-time":"2024-03-10T21:19:30Z","timestamp":1710105570000},"page":"831-835","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Symptoms and quality of life in adults with cystic fibrosis: A cross-sectional analysis of the InSPIRe:CF trial"],"prefix":"10.1016","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2964-2512","authenticated-orcid":false,"given":"Natalia","family":"Smirnova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2364-512X","authenticated-orcid":false,"given":"Jane","family":"Lowers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6016-7396","authenticated-orcid":false,"given":"Alexandre","family":"Cammarata-Mouchtouris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3794-6329","authenticated-orcid":false,"given":"Elisabeth P","family":"Dellon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2933-5926","authenticated-orcid":false,"given":"Anne","family":"Fitzpatrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5283-0792","authenticated-orcid":false,"given":"Dio","family":"Kavalieratos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcf.2024.03.005_bib0001","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.jpainsymman.2007.06.005","article-title":"Self-reported physical and psychological symptom burden in adults with cystic fibrosis","volume":"35","author":"Sawicki","year":"2008","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.jcf.2024.03.005_bib0002","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1177\/1049909116629135","article-title":"Evaluation of pain, dyspnea, and goals of care among adults with cystic fibrosis: a comprehensive palliative care survey","volume":"34","author":"Chen","year":"2017","journal-title":"Am J Hosp Palliat Care"},{"key":"10.1016\/j.jcf.2024.03.005_bib0003","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1177\/0193945919852585","article-title":"Symptom burden and unmet existential needs in adults with cystic fibrosis","volume":"41","author":"Trandel","year":"2019","journal-title":"West J Nurs Res"},{"key":"10.1016\/j.jcf.2024.03.005_bib0004","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1136\/thoraxjnl-2015-207488","article-title":"International committee on mental health in cystic fibrosis: cystic fibrosis foundation and european cystic fibrosis society consensus statements for screening and treating depression and anxiety","volume":"71","author":"Quittner","year":"2016","journal-title":"Thorax"},{"key":"10.1016\/j.jcf.2024.03.005_bib0005","article-title":"Prevalence of unmet pain and symptom management needs in adults with cystic fibrosis","author":"Dubin","year":"2022","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2024.03.005_bib0006","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.jpainsymman.2009.04.029","article-title":"Frequency and self-management of pain, dyspnea, and cough in cystic fibrosis","volume":"38","author":"Stenekes","year":"2009","journal-title":"J Pain Symptom Manag"},{"key":"10.1016\/j.jcf.2024.03.005_bib0007","unstructured":"Foundation, C.F. (2022)."},{"issue":"1","key":"10.1016\/j.jcf.2024.03.005_bib0008","first-page":"S5","article-title":"Increasing life expectancy in cystic fibrosis: advances and challenges","volume":"57","author":"McBennett","year":"2022","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jcf.2024.03.005_bib0009","doi-asserted-by":"crossref","DOI":"10.1080\/17476348.2021.1855980","article-title":"Development of elexacaftor - tezacaftor - ivacaftor: highly effective CFTR modulation for the majority of people with Cystic Fibrosis","volume":"15","author":"Middleton","year":"2021","journal-title":"Expert Rev Respir Med"},{"key":"10.1016\/j.jcf.2024.03.005_bib0010","first-page":"3","article-title":"CFTR modulator therapies - Effect on life expectancy in people with cystic fibrosis","volume":"42","author":"Balfour-Lynn","year":"2022","journal-title":"Paediatr Respir Rev"},{"key":"10.1016\/j.jcf.2024.03.005_bib0011","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1093\/jnci\/djs481","article-title":"Cancer risk in cystic fibrosis: a 20-year nationwide study from the United States","volume":"105","author":"Maisonneuve","year":"2013","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jcf.2024.03.005_bib0012","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/ppul.23033","article-title":"Overweight and obesity in patients with cystic fibrosis: a center-based analysis","volume":"50","author":"Hanna","year":"2015","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jcf.2024.03.005_bib0013","unstructured":"Cystic fibrosis foundation patient registry 2020 annual data report, https:\/\/www.cff.org\/sites\/default\/files\/2021-11\/Patient-Registry-Annual-Data-Report.pdf(2020)."},{"key":"10.1016\/j.jcf.2024.03.005_bib0014","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jcf.2017.02.011","article-title":"The CF-CARES primary palliative care model: a CF-specific structured assessment of symptoms, distress, and coping","volume":"17","author":"Friedman","year":"2018","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2024.03.005_bib0015","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.hrtlng.2018.08.003","article-title":"Evaluation of quality of life predictors in adolescents and young adults with cystic fibrosis","volume":"48","author":"Tomaszek","year":"2019","journal-title":"Heart Lung"},{"key":"10.1016\/j.jcf.2024.03.005_bib0016","doi-asserted-by":"crossref","DOI":"10.3390\/healthcare10071351","article-title":"Health-related quality of life in adults with cystic fibrosis: familial, occupational, social, and mental health predictors","volume":"10","author":"Ancel","year":"2022","journal-title":"Healthcare"},{"key":"10.1016\/j.jcf.2024.03.005_bib0017","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1089\/jpm.2020.0311","article-title":"Models of palliative care delivery for individuals with cystic fibrosis: cystic fibrosis foundation evidence-informed consensus guidelines","volume":"24","author":"Kavalieratos","year":"2021","journal-title":"J Palliat Med"},{"key":"10.1016\/j.jcf.2024.03.005_bib0018","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcf.2023.05.016","article-title":"Clinician perspectives on barriers and solutions to symptom management in cystic fibrosis","author":"Smirnova","year":"2023","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2024.03.005_bib0019","article-title":"Integrating specialist palliative care to improve care and reduce suffering: cystic fibrosis (InSPIRe:CF) - study protocol for a multicentre randomised clinical trial","volume":"9","author":"Lowers","year":"2022","journal-title":"BMJ Open Respir Res"},{"key":"10.1016\/j.jcf.2024.03.005_bib0020","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1177\/0269216319854264","article-title":"A brief, patient- and proxy-reported outcome measure in advanced illness: validity, reliability and responsiveness of the Integrated Palliative care Outcome Scale (IPOS)","volume":"33","author":"Murtagh","year":"2019","journal-title":"Palliat Med"},{"key":"10.1016\/j.jcf.2024.03.005_bib0021","doi-asserted-by":"crossref","unstructured":"AL, Q. et al. Psychometric evaluation of the cystic fibrosis questionnaire-revised in a national, US sample. Quality of life research: an international journal of quality of life aspects of treatment, care and rehabilitation 21 (2012). 10.1007\/s11136-011-0091-5.","DOI":"10.1007\/s11136-011-0091-5"},{"key":"10.1016\/j.jcf.2024.03.005_bib0022","article-title":"Patient-reported outcomes in cystic fibrosis","volume":"4","author":"CH","year":"2007","journal-title":"Proc Am Thorac Soc"},{"key":"10.1016\/j.jcf.2024.03.005_bib0023","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jpainsymman.2007.12.015","article-title":"Reliability and validity of the functional assessment of chronic illness therapy-palliative care (FACIT-Pal) scale","volume":"37","author":"Lyons","year":"2009","journal-title":"J Pain Symptom Manag"},{"key":"10.1016\/j.jcf.2024.03.005_bib0024","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa1908639","article-title":"Elexacaftor\u2013Tezacaftor\u2013Ivacaftor for cystic fibrosis with a single Phe508del allele","volume":"381","author":"Middleton","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcf.2024.03.005_bib0025","doi-asserted-by":"crossref","first-page":"e20110","DOI":"10.1016\/j.heliyon.2023.e20110","article-title":"The effect of elexacaftor\/tezacaftor\/ivacaftor on non-pulmonary symptoms in adults with cystic fibrosis","volume":"9","author":"Allgood","year":"2023","journal-title":"Heliyon"},{"key":"10.1016\/j.jcf.2024.03.005_bib0026","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1002\/ppul.24806","article-title":"Palliative care skills in CF: perspectives of adults with CF, caregivers, and CF care team members","volume":"55","author":"Trandel","year":"2020","journal-title":"Pediatr Pulmonol"}],"container-title":["Journal of Cystic Fibrosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156919932400033X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156919932400033X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T07:14:59Z","timestamp":1788246899000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S156919932400033X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S156919932400033X"],"URL":"https:\/\/doi.org\/10.1016\/j.jcf.2024.03.005","relation":{},"ISSN":["1569-1993"],"issn-type":[{"value":"1569-1993","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Symptoms and quality of life in adults with cystic fibrosis: A cross-sectional analysis of the InSPIRe:CF trial","name":"articletitle","label":"Article Title"},{"value":"Journal of Cystic Fibrosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcf.2024.03.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 European Cystic Fibrosis Society. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}